Press Releases

CytoSMART expands long-term fluorescence live-cell imaging possibilities for simultaneous comparative studies

CytoSMART Technologies has announced the launch of two new fluorescence live-cell imaging systems – the Lux3 FL Duo Kit and the Multi Lux3 FL.

Thermo Fisher Scientific Collaborates with the University of Sheffield to Advance Oligonucleotide Characterization and Analytical Workflows

Thermo Fisher Scientific and the University of Sheffield have joined forces to develop advanced end-to-end workflows for the characterization and monitoring of complex oligonucleotide and mRNA products.

Innovative Analytical Software for Enhanced Data Acquisition and Analysis

Thermo Fisher Scientific offers flexibility, customization and sample analysis capabilities with expanded software suite

Thermo Fisher Scientific and Newomics Develop New Approaches to LC-MS Analysis of Native Protein Complexes

Thermo Fisher Scientific and Newomics, a commercial-stage biotechnology company, are collaborating to develop a novel native liquid chromatography-mass spectrometry (LC−MS) platform to support various LC−MS applications.

Algorics announces acquisition of Domain Clinical Data Sciences

Algorics today announced the acquisition of Domain Clinical Data Sciences "DCDS", a clinical data services organisation based in India.

Thermo Fisher Scientific Announces Agreement with Advanced Electrophoresis Solutions Ltd to Accelerate Therapeutic Development through Cutting-Edge Protein Analysis

Thermo Fisher Scientific and Advanced Electrophoresis Solutions Ltd (AES) today announced an agreement to combine essential protein separation techniques with mass spectrometry (MS) to advance therapeutic protein development through streamlined characterization.

CD Genomics’s RNA Solutions Division Introduces Dual RNA Sequencing Service

Clinion Launches CSR Automation to Improve the Speed and Efficiency of Clinical Study Reporting

Perlara partners with Vivan Therapeutics to tackle rare genetic diseases

Today, Perlara PBC, a rare disease public benefit company, has announced a collaboration with Vivan Therapeutics, developers of personalised therapeutics, to identify novel therapeutics for rare genetic diseases.

Sygnature Discovery expands into early CMC development

Sygnature Discovery, a leading Drug Discovery Contract Research Organisation, has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line, located at its headquarters in Nottingham, UK, will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials.

Celemics Partner with Strand Life Science and their StrandOmics Analysis Platform

Dear Nicole, Celemics, a Korea-based biomaterial technology leader that has developed a range of innovative biomaterials and sequencing methods used in the medical, pharmaceutical, microbiome, synthetic biology, and breeding fields, has announced a partnership with Strand Life Sciences, a leading precision medicine informatics company.

ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford

ENPICOM, an innovative bioinformatics software engineering company, has announced the upcoming expansion of the IGX Platform’s capabilities towards advanced liability prediction.

Singapore-UK team to develop a novel device to reduce chemotherapy side-effects

A global team made up of clinicians and scientists working with UK based Paxman has been set up to develop a novel device to reduce chemotherapy side effects — Chemotherapy-induced neuropathy (CIPN).

Community Wellness Announces Partnership with Kentucky Hospital Association

Community Wellness, a leading national provider of Remote Patient Monitoring (RPM) services, has announced a new partnership with the Kentucky Hospital Association (KHA) and their shared services division, KHA Solutions Group.

Quantify Research opens new offices in Denmark and Norway

Quantify Research announces their expansion into Denmark and Norway to expand the breadth and depth of their Nordic service offerings.

3Brain AG CorePlate™ technology combines microchips and AI in a revolutionary new approach to drug discovery

3Brain AG has announced a new technology that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials.

Dolomite Bio’s distributor list expands globally

Dolomite Bio, a company that creates innovative products for high throughput single cell research, has announced the expansion of their current list of distributors.

Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation

Protheragen MedAI Offers Comprehensive Solutions for Drug Research and Development, Medical Imaging and Medical Therapy and Research System

CD Formulation Announces to Optimize Stability Analysis for Drug Pre-formulation Research